AbbVie Inc. (ABBV) — Financial statements
Income statement, balance sheet, and cash flow for AbbVie Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 61,160↑8.6% | 56,334↑3.7% | 54,318↓6.4% | 58,054↑3.3% | 56,197 | |
| Cost of Revenue | 18,204↑7.7% | 16,904↓17.2% | 20,415↑17.2% | 17,414↓0.2% | 17,446 | |
| Gross Profit | 42,956↑8.9% | 39,430↑16.3% | 33,903↓16.6% | 40,640↑4.9% | 38,751 | |
| Operating Expenses | ||||||
| R&D Expenses | 9,096↓28.9% | 12,791↑66.7% | 7,675↑17.9% | 6,510↓19.1% | 8,046 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 14,010↓5.0% | 14,752↑14.6% | 12,872↓15.6% | 15,260↑23.6% | 12,349 | |
| Other Expenses | -241↓108.8% | 2,750↑359.1% | 599↓20.5% | 753↑74.3% | 432 | |
| Operating Expenses | 22,865↓24.5% | 30,293↑43.3% | 21,146↓6.1% | 22,523↑8.1% | 20,827 | |
| Total Costs & Expenses | 41,069↓13.0% | 47,197↑13.6% | 41,561↑4.1% | 39,937↑4.3% | 38,273 | |
| Operating Results | ||||||
| Operating Income | 20,091↑119.9% | 9,137↓28.4% | 12,757↓29.6% | 18,117↑1.1% | 17,924 | |
| Depreciation & Amortization | 8,139↓2.9% | 8,386↓3.6% | 8,698↑2.7% | 8,467↓0.6% | 8,521 | |
| EBITDA | 17,629↑18.2% | 14,910↓13.2% | 17,172↓29.0% | 24,174↑1.0% | 23,933 | |
| EBIT | 9,490↑45.5% | 6,524↓23.0% | 8,474↓46.0% | 15,707↑1.9% | 15,412 | |
| Interest & Other Income | ||||||
| Net Interest Income | -2,627↓21.6% | -2,160↓28.3% | -1,684↑17.6% | -2,044↑14.3% | -2,384 | |
| Interest Income | 266↓59.0% | 648↑20.0% | 540↑190.3% | 186↑376.9% | 39 | |
| Interest Expense | 2,893↑3.0% | 2,808↑26.3% | 2,224↓0.3% | 2,230↓8.0% | 2,423 | |
| Non-Operating Income | 10,601↑305.7% | 2,613↓39.0% | 4,283↑77.7% | 2,410↓4.1% | 2,512 | |
| Other Income / Expenses | -13,494↓148.9% | -5,421↑16.7% | -6,507↓40.2% | -4,640↑6.0% | -4,935 | |
| Income Before Tax | 6,597↑77.5% | 3,716↓40.5% | 6,250↓53.6% | 13,477↑3.8% | 12,989 | |
| Income Tax Expense | 2,364↑514.7% | -570↓141.4% | 1,377↓15.6% | 1,632↑13.3% | 1,440 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 4,233↓1.2% | 4,286↓12.0% | 4,873↓58.9% | 11,845↑2.6% | 11,549 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 4,226↓1.2% | 4,278↓12.0% | 4,863↓58.9% | 11,836↑2.5% | 11,542 | |
| Bottom-Line Net Income | 4,196↓1.0% | 4,238↓12.1% | 4,820↓59.1% | 11,782↑2.7% | 11,468 | |
| EPS (Basic) | 2.37↓1.2% | 2.40↓12.1% | 2.73↓58.9% | 6.65↑2.6% | 6.48 | |
| EPS (Diluted) | 2.37↓0.8% | 2.39↓12.1% | 2.72↓59.0% | 6.63↑2.8% | 6.45 | |
| Weighted Average Shares | 1,780↑0.6% | 1,769↑0.1% | 1,768↓0.2% | 1,771↑0.1% | 1,770 | |
| Weighted Average Diluted Shares | 1,774↑0.1% | 1,773↑0.0% | 1,773↓0.3% | 1,778↑0.1% | 1,777 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.